Florence Dalenc
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Cancer Research top 1%
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Mario CamponeHenri RochéMarc PoirotThomas BachelotAnthony GonçalvèsSandrine Silvente‐PoirotJean-Marc FerreroVéronique Dièras
- Topics
- Cancer Treatment and Pharmacology (71 papers)Advanced Breast Cancer Therapies (64 papers)Breast Cancer Treatment Studies (57 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Florence Dalenc
195 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 2.6k
- Pulmonary and Respiratory Medicine 1.6k
- Cancer Research 1.3k
- Molecular Biology 1.3k
- Radiology, Nuclear Medicine and Imaging 428
Countries citing papers authored by Florence Dalenc
This map shows the geographic impact of Florence Dalenc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Dalenc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Dalenc more than expected).
Fields of papers citing papers by Florence Dalenc
This network shows the impact of papers produced by Florence Dalenc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Dalenc. The network helps show where Florence Dalenc may publish in the future.
Co-authorship network of co-authors of Florence Dalenc
This figure shows the co-authorship network connecting the top 25 collaborators of Florence Dalenc. A scholar is included among the top collaborators of Florence Dalenc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Dalenc. Florence Dalenc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 4 | |
| 5 | 28 | |
| 6 | 5 | |
| 7 | 12 | |
| 8 | 5 | |
| 9 | Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancerbreakdown → | 176 |
| 10 | 6 | |
| 11 | 11 | |
| 12 | 6 | |
| 13 | 9 | |
| 14 | 18 | |
| 15 | 28 | |
| 16 | A phase 1b study of Trebananib plus Paclitaxel and Trastuzumab or Capecitabine and Lapatinib in patients with HER2+ locally recurrent or metastatic breast cancer | 1 |
| 17 | 251 | |
| 18 | 10 | |
| 19 | 21 | |
| 20 | 208 |
About Florence Dalenc
Florence Dalenc is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 209 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (71 papers), Advanced Breast Cancer Therapies (64 papers) and Breast Cancer Treatment Studies (57 papers). The work is most often cited by research in Oncology (2.6k citations), Cancer Research (1.3k citations) and Pulmonary and Respiratory Medicine (1.6k citations). Florence Dalenc has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Mario Campone, Henri Roché, Marc Poirot, Thomas Bachelot, Anthony Gonçalvès, Sandrine Silvente‐Poirot, Jean-Marc Ferrero, Véronique Dièras, Hope S. Rugo and Marta Jimenez. Their work appears in journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.